Authors:
KAATZ GW
SEO SM
AESCHLIMANN JR
HOULIHAN HH
MERCIER RC
RYBAK MJ
Citation: Gw. Kaatz et al., EFFICACY OF LY333328 AGAINST EXPERIMENTAL METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS ENDOCARDITIS, Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 981-983
Authors:
KAATZ GW
SEO SM
AESCHLIMANN JR
HOULIHAN HH
MERCIER RC
RYBAK MJ
Citation: Gw. Kaatz et al., EFFICACY OF TROVAFLOXACIN AGAINST EXPERIMENTAL STAPHYLOCOCCUS-AUREUS ENDOCARDITIS, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 254-256
Citation: Rc. Mercier et al., PHARMACODYNAMIC EVALUATION OF A NEW GLYCOPEPTIDE, LY333328, AND IN-VITRO ACTIVITY AGAINST STAPHYLOCOCCUS-AUREUS AND ENTEROCOCCUS-FAECIUM, Antimicrobial agents and chemotherapy, 41(6), 1997, pp. 1307-1312
Citation: Mj. Rybak et al., PHARMACODYNAMICS OF RP-59500 (QUINUPRISTIN-DALFOPRISTIN) ADMINISTEREDBY INTERMITTENT VERSUS CONTINUOUS-INFUSION AGAINST STAPHYLOCOCCUS-AUREUS-INFECTED FIBRIN-PLATELET CLOTS IN AN IN-VITRO INFECTION MODEL, Antimicrobial agents and chemotherapy, 41(6), 1997, pp. 1359-1363
Citation: Hh. Houlihan et al., PHARMACODYNAMICS OF VANCOMYCIN ALONE AND IN COMBINATION WITH GENTAMICIN AT VARIOUS DOSING INTERVALS AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS-INFECTED FIBRIN-PLATELET CLOTS IN AN IN-VITRO INFECTION MODEL, Antimicrobial agents and chemotherapy, 41(11), 1997, pp. 2497-2501